News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
380,151 Results
Type
Article (25872)
Company Profile (60)
Press Release (354219)
Section
Business (104244)
Career Advice (449)
Deals (16872)
Drug Delivery (50)
Drug Development (47580)
Employer Resources (47)
FDA (12251)
Job Trends (8435)
News (185877)
Policy (19405)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1743)
Accelerated approval (1)
Adcomms (8)
Allergies (68)
Alliances (26702)
ALS (52)
Alzheimer's disease (793)
Antibody-drug conjugate (ADC) (40)
Approvals (12301)
Artificial intelligence (152)
Autoimmune disease (7)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (35)
Biotechnology (39)
Bladder cancer (44)
Brain cancer (15)
Breast cancer (168)
Cancer (1251)
Cardiovascular disease (106)
Career advice (406)
Career pathing (13)
CAR-T (64)
Cell therapy (189)
Cervical cancer (12)
Clinical research (40305)
Collaboration (408)
Compensation (111)
Complete response letters (9)
COVID-19 (1486)
CRISPR (10)
C-suite (119)
Cystic fibrosis (41)
Data (1345)
Decentralized trials (2)
Denatured (16)
Depression (27)
Diabetes (161)
Diagnostics (3496)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (48)
Drug pricing (53)
Drug shortages (21)
Duchenne muscular dystrophy (46)
Earnings (36707)
Editorial (18)
Employer branding (6)
Employer resources (44)
Events (51407)
Executive appointments (391)
FDA (13120)
Featured Employer (15)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (375)
Gene editing (32)
Generative AI (10)
Gene therapy (118)
GLP-1 (380)
Government (3014)
Grass and pollen (3)
Guidances (34)
Healthcare (12184)
Huntington's disease (9)
IgA nephropathy (13)
Immunology and inflammation (35)
Indications (18)
Infectious disease (1549)
Inflammatory bowel disease (77)
Inflation Reduction Act (4)
Influenza (22)
Intellectual property (45)
Interviews (40)
IPO (7033)
IRA (19)
Job creations (1838)
Job search strategy (378)
Kidney cancer (7)
Labor market (8)
Layoffs (164)
Leadership (3)
Legal (3628)
Liver cancer (53)
Lung cancer (212)
Lymphoma (83)
Machine learning (1)
Management (17)
Manufacturing (91)
MASH (42)
Medical device (12847)
Medtech (12850)
Mergers & acquisitions (10100)
Metabolic disorders (395)
Multiple sclerosis (46)
NASH (11)
Neurodegenerative disease (42)
Neuropsychiatric disorders (9)
Neuroscience (1081)
NextGen: Class of 2025 (3930)
Non-profit (2820)
Northern California (1213)
Now hiring (15)
Obesity (205)
Opinion (69)
Ovarian cancer (49)
Pain (57)
Pancreatic cancer (48)
Parkinson's disease (78)
Partnered (10)
Patents (96)
Patient recruitment (69)
Peanut (37)
People (34562)
Pharmaceutical (18)
Pharmacy benefit managers (11)
Phase I (11544)
Phase II (17456)
Phase III (14339)
Pipeline (572)
Podcasts (24)
Policy (48)
Postmarket research (1668)
Preclinical (3580)
Press Release (18)
Prostate cancer (66)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (170)
Real estate (2842)
Recruiting (16)
Regulatory (14110)
Reports (16)
Research institute (1605)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (17)
Schizophrenia (45)
Series A (60)
Series B (43)
Service/supplier (3)
Sickle cell disease (20)
Southern California (1069)
Special edition (3)
Spinal muscular atrophy (102)
Sponsored (12)
Startups (2119)
Stomach cancer (8)
Supply chain (33)
The Weekly (7)
United States (11636)
Vaccines (335)
Venture capitalists (13)
Webinars (7)
Weight loss (134)
Women's health (16)
Worklife (4)
Date
Today (70)
Last 7 days (355)
Last 30 days (1453)
Last 365 days (19017)
2025 (4336)
2024 (19849)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32192)
2019 (28413)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21195)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (353)
Alabama (17)
Alaska (2)
Arizona (112)
Arkansas (10)
Asia (24446)
Australia (3868)
California (2749)
Canada (1130)
China (332)
Colorado (151)
Connecticut (161)
Delaware (99)
Europe (47684)
Florida (494)
Georgia (117)
Idaho (33)
Illinois (331)
India (13)
Indiana (211)
Iowa (2)
Japan (103)
Kansas (70)
Kentucky (12)
Louisiana (5)
Maine (27)
Maryland (595)
Massachusetts (1920)
Michigan (101)
Minnesota (254)
Mississippi (2)
Missouri (48)
Montana (18)
Nebraska (18)
Nevada (28)
New Hampshire (59)
New Jersey (1016)
New Mexico (9)
New York (857)
North Carolina (523)
North Dakota (3)
Northern California (1213)
Ohio (122)
Oklahoma (3)
Oregon (23)
Pennsylvania (752)
Puerto Rico (7)
Rhode Island (20)
South America (520)
South Carolina (16)
Southern California (1069)
Tennessee (69)
Texas (486)
Utah (100)
Virginia (69)
Washington D.C. (36)
Washington State (209)
West Virginia (3)
Wisconsin (37)
380,151 Results for "sequana medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press release: Sequana Medical announces 2024 Full Year Results and 2025 Outlook
March 18, 2025
·
28 min read
Press Releases
Press release: Sequana Medical to Attend the “VFB Happening 2025” in Ghent, Belgium on Saturday, 29 March 2025
March 27, 2025
·
3 min read
Press Releases
Press release: Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation
March 20, 2025
·
7 min read
Press Releases
Press release: Sequana Medical Announces New Share Capital Amount and New Number of Shares following Loan Conversions
January 24, 2025
·
9 min read
Press Releases
Press Release: Sequana Medical announces update on second tranche of convertible bridge loan
December 2, 2024
·
4 min read
Sequana Medical announces data on alfapump® safety and quality of life to be presented at EASL Congress 2024
Sequana Medical NV announces data from its North American pivotal POSEIDON study of the alfapump® demonstrating significantly improved quality of life focused on ascites symptoms and physical functions compared to baseline, which is not seen in refractory ascites patients enrolled contemporaneously in the prospective NACSELD3 cohort.
June 6, 2024
·
8 min read
Press Releases
Press Release: Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024
November 20, 2024
·
4 min read
Press Releases
Press release: Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis
December 23, 2024
·
12 min read
Press Releases
Press Release: Sequana Medical Announces New Share Capital Amount and New Number of Shares
November 15, 2024
·
7 min read
Policy
Press news: Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®
Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces the agreed outcome of the “Day 100” meetingi with the US Food and Drug Administration, following receipt of the “Day 90” major deficiency Letter.
May 22, 2024
·
8 min read
1 of 38,016
Next
